ICES' innovation partner Hyphens Pharma signs MOU with A*ccelerate
A local innovation partner of ICES, Hyphens Pharma, has signed a five-year Memorandum of Understanding (MOU) with A*STAR’s commercialisation arm A*ccelerate on 21 Mar 2019 which will strengthen the relationship between both entities. The MOU was signed at Hyphens Pharma’s opening ceremony of its corporate headquarters and integrated facility in Singapore. Hyphens Pharma has worked closely with A*STAR since 2014 and embarked on research collaborations in areas such as product formulation and encapsulation, which are core capabilities of ICES. The opening ceremony was graced by guest-of-honour Dr Koh Poh Koon, Senior Minister of State for Trade and Industry.
From left: Mr V Ravi, ICES; Dr Peter Nagler, Executive Director, ICES; Mr Lim See Wah, Chairman & Executive Director, Hyphens Pharma; Dr Koh Poh Koon, Senior Minister of State, Ministry of Trade & Industry; Mr Philip Lim, CEO, A*ccelerate Technologies; Ms Neo Kah Yean. Senior Vice President, Commercialisation for Biomedical Sciences, A*ccelerate Technologies; Dr Benjamin Seet, Executive Director, Biomedical Research Council. Photograph courtesy of Hyphens Pharma.
This story was reported in various media channels, including The Straits Times, Lianhe Zaobao, and Channel News Asia.